Catalog Number 1120300-15 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Angina (1710); Atrial Fibrillation (1729); Myocardial Infarction (1969); Thrombosis (2100)
|
Event Date 05/17/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
It was reported that on (b)(6) 2019, a 3.0x15mm xience alpine stent was successfully implanted proximal right coronary artery (rca).On (b)(6) 2019, the patient was hospitalized for angina.The patient was in atrial fibrillation and an st elevated myocardial infarction (stemi) was diagnosed.That same day, proximal rca stent thrombosis was observed.As treatment, another percutaneous intervention (revascularization) was performed in the proximal rca.Per physician, there was no device malfunction.No additional information was provided regarding this issue.
|
|
Manufacturer Narrative
|
Internal file number: (b)(4).
|
|
Manufacturer Narrative
|
Internal file number - (b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect(s) of angina, atrial fibrillation, myocardial infarction, and thrombosis are listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effect(s) of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|